PDCD1 and glioma: Recently, one study demonstrated that combination of PD-1 inhibition and the mIDH1 inhibitor BAY1436032 extended the survival of mice implanted with GL261-IDH1R132H glioma cells by overriding the immune suppressive environment mediated by (R)-2-HG (318).